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Repair of the skeletal system is one of the principal research problems in medical science is 
closely associated with the field of material engineering. The reasons for using bone 
implants and grafts include injuries, infections, neoplasms and other hard tissue lesions. 
Bone replacement materials are predominantly used in medical disciplines such as 
dentistry, dental surgery, maxillofacial surgery and plastic surgery, as well as in orthopedics 
and traumatology (Barradas et al., 2011; Kao & Scott, 2007; Precheur, 2007). 
From a biological, immunological, and legal point of view, autogenous bone grafting still 
remains a very popular method in reconstruction following skeletal loss (Block, 2002; 
Giannoudis et al., 2005). Factors considered in the selection of the source of the bone graft 
include, among others, the ease of surgical access and the volume of bone mass required 
(Precheur, 2007). The type of autogenous bone used as a graft (cortical bone vs. cancellous 
bone) should also be considered. For instance, the higher content of morphogenetic proteins 
(BMPs) in cortical bone means that grafts of this type induce the process of bone growth 
more effectively than cancellous bone grafts. Nonetheless, skeletal reconstruction with 
autogenous bone grafts always requires additional surgical manipulations that constitute an 
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increased burden to the patient and prolong the duration of the procedure. Another very 
frequent limitation of using autogenous bone is its poor quality, when there is a skeletal 
system disorder (e.g. osteoporosis) (Bohner, 2010; Giannoudis et al., 2005). Allogenic 
implants derived from the structures of human bones can be one alternative to autogenous 
grafts (Ferreira, 2007). Mineralized (FDBA) and demineralized (DFDBA) forms of such 
implants, additionally subjected to lyophilization, are most frequently used in 
reconstructive surgery. An advantage of demineralized bone arises from the fact that the 
organic bone matrix (collagen fibers) has to be exposed in order to remove its mineral 
components, and therefore so-called matrix proteins (e.g. morphogenetic proteins) can 
easily diffuse into the implantation site and work osteoinductively (Barradas et al., 2011). 
Xenogenic implants also play an important role in reconstructive bone surgery. These 
implants are made of skeletal material obtained from animals (Merkx et al., 2003), in most 
cases from equine, bovine or porcine bones. Animal material is processed by means of 
thermal treatment in order to deplete it completely of its organic components (Barakat et al., 
2009). As a result, implants lose their immunogenic properties and become neutral to hosts 
(Liu et al., 2008). Therefore, ready to use preparations for bone replacement (Bio-Oss®, 
Endobone®) are most frequently available in deproteinized forms (DBBM) (Accorsi-
Mendonça et al., 2008). Due to their osteoconductive properties they can serve as an inactive 
scaffold or platform for the maturation of bone cells present within the defect. They are used 
in orthopedics, dental and maxillofacial surgery, as well as in periodontology and 
implantology, etc. (Baldini et al., 2011; Cao et al., 2009; Jian et al., 2008; Merkx et al., 2003; 
Precheur, 2007; von Wattenwyl et al., 2011). The limited possibilities of modulating the 
resorption time of such preparations during skeletal tissue reconstruction, however, can be 
related to the poorer quality of bone at the site of their application. 
An alternative solution, eliminating the potential complications associated with the 
application of materials of autogenous, allogenic or xenogenic origin, is the use of alloplastic 
implants for the purpose of bone replacement. Such implants can be synthesized from both 
natural and synthetic materials (Bohner, 2010; Giannoudis et al., 2005). Bioresorbable 
ceramic based on calcium phosphate plays a distinct role amongst novel synthetic materials 
used for bone replacement (Barradas et al., 2011). Hydroxyapatite (HAp) is the principal 
representative of this group, with the widest application in reconstructive surgery. Due to 
its calcium phosphate content and natural occurrence as an inorganic substance in bones 
and teeth, hydroxyapatite is characterized by the highest biocompatibility and bioactivity of 
all currently known implant materials. Additionally, due to the osteoconductive properties 
of hydroxyapatite, and (to a lesser extent) its osteoinductive properties, hydroxyapatite-
based implants can bind directly to bone. Numerous clinical trials, supported by the results 
of histological observations, have confirmed complete biotolerance to hydroxyapatite 
ceramic, as well as its positive effects on the process of bone healing and reconstruction. 
Additionally, hydroxyapatite ceramic can initiate and stimulate various processes that are 
associated with bone formation (Bellucci et al., 2011; Ravarian et al., 2010; Yuan et al., 2001). 
Contact between bioactive ceramic and living skeletal tissue induces osteogenesis. As a 
result, an intermediate binding layer is formed between the living tissue and the implant, 
serving as a kind of biological glue. The structural similarity of calcium phosphate-based 
ceramic and the natural mineral components of bone is crucial for infiltration of the implant 
by the skeletal tissue of the host. This supports the intra-tissue application of 
hydroxyapatite-based implants whenever long-term remodeling of bone is required. Beta-
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tricalcium phosphate (betaTCP, betaCa3(PO4)2) is another calcium phosphate that has been 
used successfully in bone substitution. Its mineralogical analogue is whitlockite (TCP) 
(Barradas et al., 2011). Similar to HAp, TCP is characterized by high biocompatibility. In 
comparison to hydroxyapatite materials, it has a higher solubility in vitro and a resultant 
higher susceptibility to resorption and biodegradation in the environment of the living 
organism (Bohner, 2010; Henkel et al., 2006). TCP is considered an osteoinductive material, 
which stimulates the processes of bone reconstruction (Wang et al., 2009). Many studies, 
mostly dealing with the gradual, controlled resorption rate of calcium phosphate ceramic, 
resulted in the design of the second polymorphic variant of TCP, namely ǂTCP (Zima et al., 
2010). Similar to beta-TCP, it is formed as a result of the non-stoichiometric heating of HAp 
with a well-defined temperature and defined kinetics of thermal processing. Compared to 
beta-TCP, ǂTCP has an approximately five-fold higher susceptibility to resorption in living 
tissues, along with higher biocompatibility (Oonishi et al., 1999). The high degree of 
osteointegration of ǂTCP-based bioceramic is plausibly the result of the higher solubility of 
ǂCa3(PO4)2 than of HAp or ǃTCP. Delivered within the ceramic, calcium and phosphate ions 
constitute the material for synthesizing the layer composed of non-stoichiometric 
hydroxyapatite that binds the implant to bone (Kon et al., 1995). Some authors suggest that 
ǂTCP can be cytotoxic, probably due to pH changes that are induced in vitro (Santos et al., 
2002). These suggestions, however, were not confirmed during in vivo studies, and ǂTCP is 
included in many commercially available bone cements. Since the 1990s, biphasic HAp-
ǃTCP ceramic (BCP biphasic calcium phosphate) has also been used in the reconstruction of 
skeletal defects (Deculsi, 1998, Deculsi et al., 2003; Fellah et al., 2008; Schwarz et al., 2007). 
Bio-glass and apatite-wollastonite glass-ceramic also play an important role amongst the 
bioactive materials used in the processes of bone synthesis. The biological activity of glass 
and glass-derived crystalline materials (glass-ceramic materials) is mostly exploited for the 
manufacture of surface-active implants or implants that can be resorbed in the human body 
(Giannoudis et al., 2005). The composition of surface-active materials is selected in order to 
enable interactions between the physiological environment and certain components of the 
implant. As a result, living tissue is bound to the implant surface. Resorbable glass is 
characterized by its high content of chemical elements involved in metabolic processes of 
the human body. In both cases, living tissues can infiltrate the implant and bind it directly to 
the bone. These processes result not only from the chemical composition of the implants but 
also from the specific nature of the contained glass substance. The binding abilities of 
bioactive glass and glass-ceramic implants to skeletal tissue have been the subject of many 
studies. These studies confirmed the usefulness of such materials in tissue engineering, 
where they can be used in cell culture (Ferreira, 2007; Xynos et al., 2000). Their application in 
reconstructive surgery is reflected by their ability to stimulate and supporting bone 
reconstruction. In view of their confirmed ability to directly bind to skeletal tissue, they have 
been used successfully in various stomatological disciplines, including implantology, dental 
surgery and periodontology. Moreover, modern surface engineering has allowed the 
coating of metal implants with bioactive glass. Such coatings either protect surfaces of metal 
alloys against corrosion and wear, or stimulate the processes of bone formation in their 
surroundings. Additionally, resorbable glass can be used as a drug carrier, providing 
prolonged release of an active substance. Furthermore, some attempts have been made to 
combine various materials with each other to manufacture glass-containing bioactive 
composites, used as the components of binders, among others (Bellucci et al., 2011). These 
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experiments were aimed at obtaining biomaterials with better durability parameters and 
optimal biological characteristics. Various types of bio-glass and glass-ceramics may differ 
in terms of their biological properties, depending on the technique for their synthesis 
(Bellucci et al., 2011; Yuan et al. 2001). Amongst various methods of synthesis, the 
advantages of the chemical sol-gel method are worth noting. This technique enables 
material whose biological activity is greater than products manufactured using other 
processing methods to be obtained (Ravarian et al., 2010). Moreover, the sol-gel method 
does not require high temperature processing. Additionally, this technique allows the 
production of material with a strictly defined texture and parameters. Due to the possibility 
of manufacturing porous forms, bio-glass and glass-derived crystalline materials are 
morphologically similar to bone; this facilitates their infiltration by bone cells at the 
implantation site. Additionally, the porous structure of the implant enables the supply of 
fluids and nutrients required for growth to the newly formed bone, as well as the 
elimination of metabolites (Yuan et al., 2001). Finally, the resorption rate of the implant 
material is also determined by the degree of its porosity. 
In view of the complexity of the biological environment at the implantation site, one 
principle problem of biomaterial engineering pertains to issues associated with the 
biodegradation and bioresorption of implanted biomaterials. Determination of degradation 
time and rate, and the kinetics of this process in the human body, constitute a significant 
challenge in the design of new implant materials (including bioceramic) used for the 
purposes of skeletal tissue substitution (Daculsi et al., 2003; Giannoudis et al., 2005). The 
controlled degradation rate of the implant along with the associated reconstruction of 
skeletal tissue should result in the formation of bone tissue resembling its natural structure 
as closely as possible, both at the biological and physico-mechanical levels. One of many 
methods allowing for the controlled biodegradation of bone replacement materials is the 
design of implants made of various composites or mixtures. Combining two or more 
different materials results in the manufacture of an absolutely new composite biomaterial, 
which is frequently superior in terms of biological and mechanical properties. Due to its 
specific properties, bioceramic is very frequently used as a basic component of ceramic-
ceramic, metal-ceramic and polymer-ceramic systems (Thomas et al., 2005). Hydroxyapatite 
is very frequently included in bone composites, mostly due to its chemical similarity to the 
natural components of bone. Some studies have confirmed the positive effects of 
hydroxyapatite used in combination with metals, ceramic or polymers (Abu Bakar et al., 
2003; Bellucci et al., 2011; Choi et al., 2004; Daculsi et al., 2003). The results of research on 
HAp-containing composites based on resorbable polymers, mostly polylactide (PLA), 
polyglycolide (PGA), co-polymer of glycolide and lactide (PLGA) or collagen [CieĤlik et al., 
Nagata et al., 2005], seem particularly interesting. These studies confirmed the possible 
application of such composites as binding and reconstructive elements in reconstructive 
surgery, as culture media in tissue and genetic engineering, and as drug carriers (Wei & Ma, 
2004; Nagata et al., 2003). Although hydroxyapatite is characterized by high 
biocompatibility, its reactivity with living skeletal tissue is relatively low. In view of these 
findings, attempts to design composites that combine this biomaterial with markedly more 
biologically active bio-glass propose an interesting solution. Such a composite can stimulate 
osteogenesis, leading to the rapid formation of new skeletal tissue around the implant (Yuan 
et al., 2001; Ravarian et al., 2010). Biological tests of SiO2-CaO-Mg/natural HAp (bovine 
bone) composite obtained by means of thermal plasma processing have confirmed its lack of 
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toxicity. Moreover, the glass-ceramic contained in this composite was confirmed to 
stimulate the growth and proliferation of human fibroblasts (Yoganand et al., 2010). 
Attempts at bone replacement with materials obtained by combining autogenous bone and 
deproteinized bovine bone constitute another example of the potential optimization of 
biological conditions for new skeletal tissue growth within a skeletal defect. The inclusion of 
autogenous material with osteoinductive properties in such composites results in the 
enhanced formation of better quality bone (Kim et al., 2009; Pripatnanont et al., 2009; 
Thorwarth et al., 2006; Thuaksuban et al., 2010). In vitro cellular studies have confirmed that 
allogenic materials of human origin (demineralized bone matrix, deproteinized bone) may 
also have some osteoinductive activity. This activity was confirmed by an increase in 
alkaline phosphatase (ALP), osteocalcin (OC) and Ca2+ concentrations observed in human 
bone marrow stromal osteoprogenitor cells (hBMSCs) cultured for three weeks in medium 
based on human bone components (Zhang et al., 2009). 
The increasing demand for bone replacement materials stimulated us to design original 
composite materials for use in the regeneration of skeletal defects, characterized by both 
osteoinductive and osteoconductive properties. In designing such composites, we have used 
well-described biomaterials that have been applied successfully to skeletal defect 
regeneration, namely bio-glass (BG) and tricalcium phosphate (TCP). Lyophilized human 
bone obtained from a tissue bank served as a base for designing three types of mixtures: 1) 
human bone/bio-glass; 2) human bone/TCP; and 3) human bone/bio-glass/TCP. Such 
variants of material combinations enabled us to analyze the effects of particular components 
on the process of bone formation, and specifically on its dynamics and on the quality of 
newly formed bone. Also, the selection of the components included among the analyzed 
materials (mixtures) was not accidental. We have assumed that both bio-glass and 
tricalcium phosphate will activate and stimulate osteoblasts to dynamically grow on a 
biological scaffold of lyophilized human bone, thereby providing optimal biological 
conditions for the formation of full value bone. 
2. Material 
The materials used in the study included lyophilized, deproteinized human bone (B) – 
group B, and its mixtures with: 1) bio-glass (BG) in a proportion of 80:20% weight ratio 
(B:BG) – group B+BG; 2) tricalcium phosphate (TCP) in a proportion of 80:20% weight ratio 
(B:TCP) – group B+TCP; 3) bio-glass and tricalcium phosphate in a proportion of 70:15:15% 
weight ratio (B:BG:TCP) – group B+BG+TCP. The deproteinized human bone and all other 
components used in the mixtures were in a granulated form with diameters ranging from 
0.3 to 0.5 mm. 
Human bone used in this study was obtained from the Tissue Bank of the Regional Center 
of Blood Donation and Treatment in Katowice (Poland). It was cancellous bone subjected to 
lyophilization, deep freezing and irradiation sterilization with a dose of 35 kGy. 
The bio-glass was made from the CaO-SiO2-P2O5 system with the use of the sol-gel 
technology, in the laboratory of the Department of Glass and Amorphous Coatings at the 
AGH Science and Technology University in Cracow, Poland. Its high-calcium A2 variety 
was used (54% mol. CaO) with a density of 2.9082 g/cm³, a dominating glassy phase and the 
beginnings of apatite crystallization. The thermal treatment of the bio-glass was performed 
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at a temperature of 800˚C, and its specific surface area (calculated by BET method) 
amounted to 57.8166 m2/g. 
Resorbable, monophasic ǃTCP ceramic – a salt of trialkaline orthophosphoric acid Ca3(PO4)2 
– was synthesized from powdered components obtained by means of wet synthesis in the 
Bioceramic Laboratory of the Department of Ceramic and Fire Resistant Material 
Technology at the AGH Science and Technology University in Cracow, Poland (ģlósarczyk 
& Paszkiewicz, 2005; Zima at al., 2010). The reagents included CaO (obtained by means of 
calcination of Ca(OH)2 – pure for analysis; MERCK, Poland), and H3PO4 (pure for analysis; 
POCH, Poland).    
3. In vivo animal experiments 
The study was carried out on a group of 48 guinea pigs, with an equal number of both sexes, 
and weights ranging from 500 to 600 grams. The animals were divided randomly into four 
groups, which corresponded to 12 animals for each studied composite material (6 males and 
6 females). The animal experiments were performed on the 7th, 14th, and 21st days of the 
study, as well as after the 4th, 8th and 12th experimental weeks. Two guinea pigs (one male 
and one female) were examined in each experiment. All animal surgical procedures were 
performed at the Central Experimental Animal Farm at the Medical University of Silesia and 
were granted permission by the university’s Bioethical Board for Experimental Animals. 
Before starting any surgical procedures, the animals received general anesthesia with 
thiopental (0.4 g/kg b.w.). Bone defects (6 mm in diameter and 3 mm in depth) were formed 
bilaterally on the external surface of the mandibular trunk, 2 mm below its lower edge 
(between the radices of the incisive and molar teeth) with the aid of a rosette burr placed in 
the straight hand-piece of a dental machine (Fig.1a). Depending on the experimental group, 
bone defects on the right side of the mandible were filled with: 1) a preparation of 
deproteinized human bone (group B), 2) a mixture of deproteinized human bone and bio-
glass (group B+BG), 3) a mixture of deproteinized human bone and tricalcium phosphate 
(group B+TCP), or 4) a mixture of deproteinized human bone with bio-glass and tricalcium 
phosphate (group B+BG+TCP). Before implantation into the mandibular bone defect, each 
material was mixed with the animal’s blood obtained from the surgical wound (Fig. 1b) in a 
 
Fig. 1. Bone defect in the mandibular trunk of the experimental animal: a) defect prepared 
for filling with implant based on deproteinized human bone; b) defect filled with the 
mixture of deproteinized human bone and bio-glass with animal’s blood; c) control defect 
filled with postoperatively clotted blood 
a b c 
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proportion of 25:75% weight ratio (examined material to blood). Blood served as a binder, 
supplying the implanted material with organic components. Additionally, it prevented the 
displacement of the implanted granules from within the bone defect, and facilitated their 
insertion. The defect on the left side of the mandible was left to fill postoperatively with 
clotted blood and undergo spontaneous healing (Fig.1c), and was considered a control to the 
right mandibular defect in each animal (control group). The bilateral wounds were closed in 
multiple layers with Dexon 4.0 sutures. 
4. Methods of examination 
On each examination day, all guinea pigs were clinically evaluated for surgical wound 
healing and general condition. Additionally, radiographs were taken in order to assess the 
regeneration of mandibular bone defects. Newly formed skeletal tissue in the defects was 
also analyzed quantitatively and qualitatively in terms of bone mineral density at the 
implantation site (computed tomography and radiographic densitometry). Following 
euthanasia with Morbital (sodium pentobarbital 133.3 mg/mL and pentobarbital 26.7 
mg/mL, 1-2 mL/kg b.w.), the operated area and surrounding tissues were examined 
macroscopically. Moreover, tissue specimens from the euthanized animals were subjected to 
histopathologic analysis of the skeletal tissue and bone marrow at the implantation site and 
at its periphery, including the healing rate of the skeletal tissue and the soft and hard tissue 
reactions to the implanted material. Histopathologic analysis also included organs involved 
in detoxification of the body (i.e. liver and kidneys). 
Radiographs of the mandibular trunk with the sites of the bone defects were taken with a 
Heliodent type MD/D – 3195 nr 051692 apparatus (SIEMENS), and AGFA DENTUS M2 
CONFORT films for axial pictures (75 mm x 65mm), using the following exposure 
conditions: 0.16 s, 7 mA and 60 kV. 
The tissue specimens taken for the histopathologic examinations were preserved in a 10% 
solution of buffered formalin. The osseous tissue was decalcified either in a 10% solution of 
disodium versenate, or electrolytically in Romeis liquid (80 mL of hydrochloric acid + 100 
mL of formic acid, diluted to make 1000 mL with water) using PW23 bone decalcifier and an 
electric current of 0.5A. Next, all the tissues were routinely processed in Technicon’s Duo 
autotechnicon using the sequence of 96% alcohol, acetone and xylene. They were then 
embedded in paraplast. The obtained cubes were then shaved on a Microm HM335E 
rotating microtome. The shavings (4-6 microns in thickness) were put onto basic slides, 
deparaffinized, and stained with hematoxylin and eosin (H&E). They were subsequently 
mounted with Canada balsam. Histologic slides were analyzed under an Olympus BX50 
light microscope equipped with a set for optical (Olympus SC35) and digital 
microphotography (Olympus Canmedia C-5050 Zoom), at 40 to 400 x magnification. 
Additionally, the slides were consulted by other histologists using a dual-head Nikon 
Labophot-2 microscope. 
Bone mineral density (BMD) was determined by means of dual-energy X-ray absorptiometry 
(DXA) with a DPX-L densitometer (LUNAR Radiation Corporation, Madison, USA) using 
Small Animal Appendicular scanning. Total bone mineral density (BMD; g/cm2) was 
determined on the basis of examination of the entire area of the transverse cross-section of the 
bone defect (28.26 mm2), analyzed as 0.5 mm2 to 3 mm2 sections. One hundred and twenty 
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BMD measurements were taken in each group (corresponding to 20 measurements per 
experimental day). In most cases, reproducible results were not included in further analysis; 
only unique values and the most frequent reproducible values were analyzed, which 
corresponded to 10 BMD measurements for each day of examination. Additionally, the BMD 
of the normal mandibular trunk of the guinea pig was determined for the purpose of 
comparative analysis. Based on 10 consecutive measurements, this value was estimated at 0.51 
± 0.001 g/cm2. During the measurements, the densitometer was regularly calibrated and 
controlled according to the manufacturer’s recommendations. Both DXA measurements and 
BMD result analysis were performed by the same investigator. 
Additionally, computed tomography (CT) was used to determine the bone mineral density, 
expressed in Hounsfield units (HU). These measurements were taken using a Somatom 
Emotion 6 scanner (Siemens; exposure parameters: 13.4 s, 14 mA, 130 kV). Transverse cross-
sections of the mandible were visualized in 2 mm slices. Then, cross-sections including the 
area of the bone defect were selected and analyzed using Volume Viewer software. In each 
experimental group, six measurements were taken for each examination day. Additionally, 
six measurements of the normal mandible were taken for the purpose of comparative 
analysis. Based on these measurements, the normal bone mineral density was determined to 
be 1218 ± 15.2 HU. 
The results of bone density are presented as mean values ± standard deviation. Variables 
distribution was evaluated by the Shapiro-Wilk test. Homogeneity of variance was assessed 
by the Levene test. ANOVA for repeated measurements with contrasts analysis were done 
to assess time and preparation of deproteinized human bone type interaction. The Mauchley 
test was done to check sphericity. Differences were considered to be statistically significant 
at p<0.05. All calculations were performed using the commercially available statistical 
package Statistica 9.0. 
5. Results 
5.1 Clinical observations 
Throughout the entire study period, no complications in surgical wound healing were 
observed in animals of any experimental group. The guinea pigs were calm, which 
suggested a lack of pain. The animals ate and drank water normally, and neither scraped 
against the cage nor scratched their wounds during the entire postoperative period. Also, 
wound dehiscence was not observed in any of the groups. 
Tissue edema over the surgical skin wounds resolved 3 to 5 days following surgery and was 
replaced by protrusions of the tissue. There were no signs of excessive fluid accumulation 
around the wound or of hematoma formation, but in some animals skin redness was 
observed around the stitches. In most animals, tissue protrusions persisted until the 21st day 
after surgery. The stitches were removed 10 to 14 days after surgery. Over the entire study 
period, the animals gained weight gradually (in a statistically insignificant manner). 
5.2 Macroscopic examination 
Up to 14th experimental day, the sites of the implanted bone defects were clearly 
distinguishable from the surrounding tissues as clear, oval protrusions covered with delicate 
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tissue, which could be compressed elastically. Additionally, clearly distinguishable white 
granulation was visible throughout the superficial tissue in animals of the B+BG and 
B+BG+TCP groups. Probably, these granules corresponded to the bio-glass particles 
included in the material implanted in these groups. In the control group, the site of the bone 
defect was visible as a clear protrusion up to the 7th experimental day. On the next day of 
examination (the 14th day), however, the site was covered with a tissue whose coloration 
was darker in comparison to the surrounding tissues. 
After the 3rd experimental week, the protrusion visible over the implantation site in groups 
B+BG, B+TCP and B+BG+TCP was markedly smaller in size, and covered with a hard tissue 
of more compact texture. Coloration of the tissues covering the implantation site still 
differed from the color of normal bone. In group BG, white granulation was still visible 
throughout the superficial tissue. On the 21st day after surgery, the coloration of the bone 
defect implanted with deproteinized human bone (group B) resembled the color of the 
surrounding tissues more closely than in previous periods. In both group B and in the 
control group, clearly distinguishable small areas in the form of a dark-colored spot were 
visible within the defects. Additionally, tissue protrusion observed over the defects in the 
control group increased in size when compared to previous periods. 
Four weeks following implantation, the area of the bone defect in group B+BG was slightly 
smaller in size but still clearly distinguishable and differed in color from the surrounding 
tissues. Similar changes were observed in the B+TCP group; the implantation site in this 
group was concave, but still appeared hard when compressed. The tissue visible over the 
implantation site in group B+BG+TCP resembled the surrounding normal tissues the most 
closely when compared to the other groups. In group BG, white granulation was still visible 
throughout the superficial tissue covering the bone defect. In the control group, on the other 
hand, a large protrusion was still visible over the implantation site, with a small dark-
colored spot at its center. 
After the 8th and 12th weeks of experiment, the implantation sites of the group B animals were 
still clearly distinguishable on macroscopic examination; they were protruding and differed in 
color from the surrounding tissues. Protrusions over the implantation sites were also visible in 
group B+BG, but only up to the 8th week of the study. After this time, the implantation site 
was hardly distinguishable from the normal tissues, and only the presence of granulation, 
which was hardly visible throughout the superficial tissue, enabled its visual identification. In 
group B+BG+TCP, the implantation site could also only be localized due to the subtle 
appearance of white granulation as early as after 8 weeks of the experiment. In group B+TCP, 
no concavity was observed over the implantation site beginning from the 8th week of the 
study, and the tissue covering the defect only slightly differed in color from the surrounding 
normal bone. After 12 weeks of observation, the tissue over the bone defects in this group had 
an identical appearance to the surrounding tissues. On the last examination day, the site of the 
bone defect was distinguishable only in the control group. Although the implantation site was 
covered with hard tissue, minute concavities and dark spots were still visible on its surface.  
5.3 Radiological examinations 
Material-related differences in the rates of new skeletal tissue formation were revealed as 
early as after the 7th day of the study. In group B, spherical translucencies with regular 
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edges were observed on radiographic images, with a size corresponding to the size of the 
bone defect. The initial process of bone reconstruction, manifested by a foggy appearance 
of the implantation site, was observed no earlier than after the second experimental week 
(Fig. 2a). At that same time point, initial signs of bone formation were also observed on 
radiographic images taken in group B+BG+TCP (Fig. 5a), while in group B+BG this 
phenomenon was already visible after 7 days (Fig. 3a). Irregular translucencies at the 
implantation site were seen in this group, but a small shadow was observed in the central 
zone, whose area and intensity increased with time. Radiologic findings suggested that 
the beginning of new tissue formation was most delayed in group B+TCP (Fig. 4a) and in 
the controls (Fig. 6a). In these groups, a distinct shadow was observed no earlier than 
after the 3rd week of the experiment; this shadow was larger and more intense in B+TCP 
group. 
After the 4th week of the study, radiographic images taken in group B revealed the nearly 
complete formation of new skeletal tissue. At this point in time, indistinct translucencies 
were seen only at the periphery of the skeletal defect, suggesting osteogenesis was 
ongoing in this area. After 8 weeks of the experiment, bone reconstruction was complete 
in this group. The whole defect was excessively shadowed, suggesting that tissue with 
greater mineralization was present in this area when compared to normal bone (Fig. 2b). 
As with group B, in group B+TCP the mineralization of the implantation site was 
complete after the 8th week of the study, as suggested by a fully shadowed area of the 
bone defect visible on radiographic images (Fig. 4b). At the same time, a small 
translucency was visible in the superior-medial aspect of the bone defect in group B+BG. 
In this group, the process of bone formation was completed no earlier than after the 12th 
week of the experiment. This was confirmed by the excessive mineralization of skeletal 
tissue, manifested radiographically as a distinct shadow at the implantation site (Fig. 3b). 
In the B+BG+TCP group, a homogenous shadow was visible at the implantation site as 
early as after the 8th week of the experiment, and an incomplete process of skeletal tissue 
regeneration was suggested only by the presence of spotted translucencies. However, the 
site of the bone defect could not be distinguished from the surrounding tissues until at 
least the 12th week of the study (Fig. 5b). In the control group, the process of bone 
formation was markedly delayed, and after the 8th week of the study a distinct, 
longitudinal translucency could still be seen at the site of the bone defect. Moreover, non-
calcified areas were still visible on the last examination day despite newly formed skeletal 
tissue present within the entire area of the bone defect (Fig. 6b). 
 
Fig. 2. Radiographic images of the mandible in experimental animals. Bone defect healing in 
the presence of deproteinized human bone: a) 14th day of the study; b) 8th week of the study 
a b 
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Fig. 3. Radiographic images of the mandible in experimental animals. Bone defect healing in 
the presence of the mixture of deproteinized human bone with bio-glass: a) 7th day of the 
study; b) 12th week of the study 
 
Fig. 4. Radiographic images of the mandible in experimental animals. Bone defect healing in 
the presence of the mixture of deproteinized human bone with tricalcium phosphate: a) 21st 
day of the study; b) 8th week of the study 
 
Fig. 5. Radiographic images of the mandible in experimental animals. Bone defect healing in 
the presence of the mixture of deproteinized human bone with bio-glass and tricalcium 
phosphate: a) 14th day of the study; b) 12th week of the study 
 
Fig. 6. Radiographic images of the mandible in experimental animals. Bone defect healing on 











Tissue Regeneration – From Basic Biology to Clinical Application 
 
380 
5.4 Bone Mineral Density 
5.4.1 Radiographic densitometry 
A gradual increase in BMD was observed in all experimental groups and in the controls. The 
highest BMD value was observed after the 8th week of the study in bone defects implanted 
with B+TCP (0.400.05 g/cm2) and B+BG+TCP (0.390.05 g/cm2) (Table 1). However, these 
values were still lower than the normal BMD of the mandibular trunk determined in guinea 
pigs (0.51± 0.001 g/cm2). 
 BMD [g/cm2] 
  
Group 1st week 2nd week 3th week 4th week 8th week 12th week 
B 0.25  0.01 0.27  0.01 0.28  0.01 0.33  0.02 0.35  0.03 0.35  0.03 
B+BG 0.27  0.02 0.30  0.03 0.30  0.03 0.31  0.02 0.31  0.03 0.33  0.01 
B+TCP 0.22  0.03 0.24  0.03 0.33  0.01 0.32  0.04 0.40  0.05 0.36  0.02 
B+BG+TCP 0.23  0.03 0.28  0.02 0.32  0.03 0.35  0.04 0.39  0.05 0.38  0.02 
Control 0.24  0.01 0.25  0.01 0.22  0.02 0.34  0.01 0.33  0.04 0.32  0.02 
Table 1. Bone mineral density (BMD) of skeletal defects implanted with various materials 
and in control defects determined radiographically at various time points in the study 
The most regular increase in BMD was observed in defects implanted with B+BG+TCP, 
followed by B and B+BG. Some irregularities in the time profiles of BMD changes were 
noted, however, in animals of group B+TCP and in the controls, suggesting inhomogeneous 
formation of new skeletal tissue (Fig. 7). 
Additionally, statistical analysis revealed intergroup differences in the time profiles of BMD 
changes. The most pronounced differences were observed between groups B and B+BG – 
0.98, followed by B+BG vs. B+TCP – 0.79, and B vs. B+TCP – 0.78. Slight differences in the 
time profiles were noted between the B+BG+TCP group and other material groups, and no 
significant differences were observed when experimental groups were compared to the 
control group (Table 2). 
Profile comparison (p-values) 
 
Group Control B B+BG B+TCP
B <0.05 – – – 
B+BG <0.05 0.98 – – 
B+TCP <0.05 0.78 0.79 – 
B+BG+TCP <0.01 0.20 0.21 0.32 
Table 2. The p-values for comparison of bone mineral density (BMD) changes in time 
(profiles) between the tested material and control groups 
Moreover, a relative increase in BMD between the 1st and 12th experimental weeks was 
calculated for each group (Table 3). The highest relative increase in BMD was observed in 
bone defects in group B+BG+TCP (25.49) but the increase in the B+TCP group was only 
slightly lower (24.14). The lowest relative increase in BMD between the 1st and 12th 
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experimental weeks was observed in animals of group B+BG (9.98); the time plot of BMD 
changes in this group was closest to a vertical line. 
 
Fig. 7. Time profile of changes in bone mineral density (BMD) determined radiographically 
in bone defects implanted with various materials and in control defects 
Due to non-sphericity (Mauchley test: 0.42; p<0.001) only multivariable tests were used. We 
confirmed that there were statistically significant changes in BMD with time (F = 894.17; 
p<0.001). Moreover, the interaction between time and the type of material used (group) was 
also statistically significant (F = 35.59; p<0.001). 
 12th vs. 1st week 
  
Group |t| p 
B 17.11 <0.001 
B+BG 9.98 <0.001 
B+TCP 24.14 <0.001 
B+BG+TCP 25.49 <0.001 
Control 13.58 <0.001 
Table 3. Comparison of bone mineral density (BMD) values between the 12th and 1st weeks 
with regard to the tested material and control groups 
Finally, statistical analysis revealed several significant intergroup differences in BMD values 
determined in experimental weeks 1 and 12 (Table 4). In the earlier period, the most 
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pronounced difference was observed between groups B+BG and B+TCP (4.33), while the 
lowest difference pertained to groups B+TCP and B+BG+TCP. After 12 weeks of the 
experiment, the most pronounced difference in BMD of the bone defect was noted between 
the control group and the B+BG+TCP group, while the difference between the B and B+TCP 
groups was the lowest. 
1st week 12th week 
Groups |t| P |t| p
B vs. Control 0.70 0.48 3.63 <0.001 
B+BG vs. Control 2.48 <0.05 1.41 0.17
B+TCP vs. Control 1.85 0.07 4.54 <0.05 
B+BG+TCP vs. Control 1.27 0.21 6.40 <0.001 
B vs. B+BG 1.78 0.08 2.22 <0.05 
B vs. B+TCP 2.55 <0.05 0.91 0.37
B vs. B+BG+TCP 1.98 0.05 2.78 <0.01 
B+BG vs. B+TCP 4.33 <0.001 3.13 <0.01 
B+BG vs. B+BG+TCP 3.75 <0.001 4.99 <0.001 
B+TCP vs. B+BG+TCP 0.57 0.57 1.87 0.07
Table 4. Comparison of bone mineral density (BMD) values in the 1st and 12th weeks 
between the tested material and control groups 
We have also observed statistically significant differences in the growth of BMD with time 
between the analyzed groups (F=8.15; p<0.001). The smallest changes in BMD were yielded 
by B+BG (0.060.01), then the control group (0.080.01) and B (0.110.02). The largest 
changes were observed for B+TCP (0.140.01) and B+BG+TCP (0.160.01). For all paired 
comparisons, statistically significant differences were noted (p<0.01). 
5.4.2 Computed tomography 
Table 5 summarizes the values of bone density in the experimental groups and in the 
controls as determined by CT. A gradual increase in the density of healing bone defects was 
observed in all studied groups. After 12 weeks of the experiment, the highest values of CT 
bone density were observed in the B+BG (1014.8±53.9 HU) and B+BG+TCP (941.2±28.9 HU) 
groups, while the lowest values were noted in the controls (812.3±21.8 HU). However, the 
highest determined values of CT bone density were still lower compared to the bone density 
of the normal mandible (1218 ± 15.2 HU). 
 CT Bone Density [HU] 
  
Group 1st week 2nd week 3th week 4th week 8th week 12th week 
B 647.7 ± 79.1 784.0 ± 82.3 863.2 ± 13.3 763.8 ± 136.1 954.3 ± 56.3 902.8 ± 13.5 
B+BG 597.2 ± 48.8 730.5 ± 9.8 814.3 ± 38.1 822.5 ± 99.8 933.3 ± 22.0 1014.8 ± 53.9 
B+TCP 410.3 ± 34.0 468.2 ± 59.1 606.7 ± 41.8 804.0 ± 51.7 826.3 ± 39.3 879.2 ± 24.6 
B+BG+TCP 454.7 ± 17.1 526.3 ± 35.6 523.2 ± 27.7 725.7 ± 36.3 923.7 ± 31.8 941.2 ± 28.9 
Control 256.0 ± 20.4 510.3 ± 28.7 539.0 ± 38.3 597.8 ± 35.3 681.8 ± 19.4 812.3 ± 21.8 
Table 5. CT bone density (expressed in Hounsfield units, HU) in bone defects implanted 
with various materials and in control defects at various time points in the study 
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The most homogeneous increase in CT bone density values was observed in groups B+BG 
and B+TCP, and in the controls. Some irregularities in the time profile of bone density were, 
by contrast, noted in animals of the B and B+BG+TCP groups (Fig. 8). 
 
Fig. 8. Time profile of changes in CT bone density (expressed in Hounsfield units, HU) in 
bone defects implanted with various materials and in control defects 
Due to non-sphericity (Mauchley test: 0.0030; p<0.001) only multivariable tests were used. 
We confirmed that there were statistically significant changes in Hounsfield Units with time 
(F = 1244.88; p<0.001). Moreover, the interaction between time and the type of material used 
(group) was also statistically significant (F = 65.35; p<0.001). 
When the time profiles of CT bone density changes were compared between the studied 
groups, the only significant differences observed were between groups B and B+BG – 0.86, 
and B+TCP and B+BG+TCP – 0.30 (Table 6). 
Profile comparison (p-values)
Group Control B B+BG B+TCP
B <0.001 – – –
B+BG <0.001 0.86 – –
B+TCP <0.001 <0.001 <0.001 –
B+BG+TCP <0.001 <0.001 <0.001 0.30
Table 6. The p-values for comparison of CT bone density (expressed in Hounsfield units, 
HU) with changes in time (profiles) between the tested material and control groups 
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The most evident intragroup differences in CT bone density determined in the 1st and 12th 
experimental weeks were observed in the control group (29.77), but the differences were 
only slightly less pronounced in groups B+TCP (24.10) and B+BG+TCP (22.94). The least 
evident differences between the two analyzed time points were noted in the B (10.67) and 
B+BG (16.77) groups (Table 7). 
 12th vs. 1st week 
  
Group |t| p 
B 10.67 <0.001 
B+BG 16.77 <0.001 
B+TCP 24.10 <0.001 
B+BG+TCP 22.94 <0.001 
Control 29.77 <0.001 
Table 7. Comparison of CT bone density values (expressed in Hounsfield units, HU) 
between the 12th and 1st weeks with regard to the tested material and control groups 
After seven days of the experiment, the most pronounced intergroup differences in CT bone 
density were observed between the control group and groups B and BG. The least 
pronounced intergroup differences noted in this period pertained to groups B and B+BG. 
After 12 weeks of the study, the most evident intergroup differences in CT bone density 
were again observed between the controls and group B+BG, while the lowest differences 
were noted between groups B and B+TCP. 
 1st week 12th week 
   
Groups |t| p |t| p 
B vs. Control 16.63 <0.001 4.91 <0.001 
B+BG vs. Control 15.23 <0.001 10.29 <0.001 
B+TCP vs. Control 8.48 <0.001 3.67 <0.05 
B+BG+TCP vs. Control 10.36 <0.001 6.83 <0.001 
B vs. B+BG 1.56 0.1325 6.01 <0.001 
B vs. B+TCP 9.11 <0.001 1.39 0.1779 
B vs. B+BG+TCP 7.00 <0.001 2.14 <0.05 
B+BG vs. B+TCP 7.55 <0.001 7.40 <0.001 
B+BG vs. B+BG+TCP 5.44 <0.001 3.87 <0.001 
B+TCP vs. B+BG+TCP 2.11 <0.05 3.53 <0.01 
Table 8. Comparison of CT bone density (expressed in Hounsfield units, HU) values in the 
1st and 12th weeks between tested material and control groups 
We have also observed statistically significant intergroup differences in the relative increase 
in CT bone density (expressed in Hounsfield units, HU) (F = 39.22; p<0.001). The smallest 
changes in CT bone density were yielded by group B (255.267.6). Larger changes were 
observed for B+BG (417.725.7), B+TCP (468.843.3) and B+BG+TCP (486.516.5). The 
largest change was noted in the control group (556.234.4). For all paired comparisons, 
statistically significant differences (with p<0.05) were observed, with the only exception 
being a comparison between B+TCP and B+BG+TCP.  
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5.5 Histopathologic analysis 
In all analyzed groups, after 7 days of the study, mandibular bone defects had filled with 
immature fibrous tissue. Numerous, minute granules of deproteinized human bone (with no 
signs of activity) were seen in this tissue (group B). Additionally, depending on the implant 
composition, foggy fractions of bio-glass or linearly cracked deposits of tricalcium 
phosphate could be seen (in groups B+BG, B+TCP and B+BG+TCP). At the same time, 
active reconstruction of skeletal tissue was observed at the entire periphery of the bone 
defects implanted with B, B+TCP and B+BG+TCP, as suggested by the presence of ground 
substance (osteoid) containing numerous immature bone trabeculae covered with 
osteoblasts. In controls, as well as in groups B and B+BG, blood clots along with the 
remnants of necrotic bone trabeculae could be seen in the bone marrow at the base of the 
bone defect. In groups where bio-glass was implanted into the bone defect (B+BG and 
B+BG+TCP), fragments of this material formed pseudocystic structures that were covered 
with a thin connective tissue capsule comprised of fibroblasts, fibrocytes and single giant 
polynuclear cells. 
After two weeks of the experiment, the implanted bone defects were filled with mature 
fibrous connective tissue that contained collagen fibers. Only in group B could immature 
connective tissue with numerous blood vessels be seen at the periphery of the defect. 
Immature bone trabeculae were visible in this tissue, surrounded with osteoblasts. 
Depending on the implant composition, fragments of deproteinized bone granules, bio-glass 
and/or tricalcium phosphate were seen in the fibrous connective tissue. Around BG and 
TCP particles, distinct, thick-walled pseudocystic structures could be observed, containing 
numerous giant polynuclear cells. Additionally, giant polynuclear cells were frequently 
visible on the surface of deproteinized bone but they did not form distinct capsule-like 
linear structures in this location. Fragmentation of some TCP particles could be observed 
due to infiltration by cells composing the previously mentioned cystic structures. Active 
osteogenesis was evident in all analyzed groups, as manifested by the pronounced growth 
of numerous immature bone trabeculae covered with osteoblasts. This process was 
particularly intensive around the particles of implanted material. 
In group B, advanced reconstruction of bone defects was observed after three weeks of the 
study. Most bone trabeculae filling the defect were mature with either no or very little 
osteoblastic activity. Linearly placed osteoblasts, or even osteoclasts, could be seen on the 
surface of remaining trabeculae (Fig. 9). A similar advancement in the bone formation 
process was observed in B+TCP specimens: osteoid was formed on the base of connective 
fibrous tissue along with the intensive growth of numerous bone trabeculae. Some of 
these trabeculae were mature already and showed no signs of cellular activity. Skeletal 
tissue regeneration in this group was particularly enhanced around the fragments of 
deproteinized bone and tricalcium phosphate (Fig. 10). In contrast to B particles, TCP 
particles showed signs of dilution and structural fragmentation. Only a few giant 
polynuclear cells could be seen around the implants, and the previously observed cystic 
structures of TCP had only residual character. After three weeks of the study, slightly less 
advanced processes of skeletal defect healing were observed in histologic specimens from 
groups B+BG and B+BG+TCP. Growth of immature skeletal tissue was observed in these 
groups on the “scaffold” of deproteinized bone, giving the impression of the implant 
being “incorporated” into the growing bone trabeculae. Only single giant polynuclear 
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cells could be seen on the surface of specimens from group B+BG. Additionally, thin, 
linearly placed cells could be observed around some bio-glass particles, forming 
pseudocystic structures. These structures were visible mostly in areas directly adjacent to 
fibrous connective tissue. Numerous bone trabeculae were observed around the 
B+BG+TCP mixture particles, as well as in the fibrous connective tissue between the 
particles (Fig. 11). Some trabeculae were mature and showed no signs of osteoblastic 
activity on their surfaces. Some implant particles in this group were covered with giant 
polynuclear cells forming structures resembling foreign body granulomas. In the control 
group, all osteoid trabeculae were surrounded by osteoblasts still showing signs of 
osteoblastic activity. 
After four weeks of the study, only the bone defects in group B were nearly completely 
filled with mature, compact skeletal tissue. This tissue contained numerous “incorporated” 
granules of deproteinized human bone. Growing bone trabeculae with surface signs of 
osteoblastic activity could only be seen in a narrow layer of fibrous connective tissue located 
between the newly formed bone and the bottom of the defect. At the same time, mature 
cancellous skeletal tissue could only be observed at the periphery of bone defects in groups 
B+TCP and B+BG+TCP. “Incorporated” fragments of the implanted material, mostly human 
bone, were visible in this tissue. The central part of the defects was still filled with fibrous 
connective tissue, showing signs of the ongoing process of bone formation. This area also 
contained B particles and a few particles of TCP ceramic. These fragments of tricalcium 
phosphate were covered with a pseudo-capsule comprised of giant polynuclear cells, and 
were gradually fragmented and resorbed. After four weeks of the experiment, numerous 
mature bone trabeculae with no signs of cellular activity were observed in specimens from 
group B+BG (Fig. 12). Some of these trabeculae developed around B and BG particles, 
giving the impression of “incorporating” implanted material into the structure of 
reconstructed bone. Some bone defects were still partially filled with mature fibrous 
connective tissue containing numerous collagen fibers along with particles of implanted 
material. Additionally, pseudocystic structures could be observed around the BG particles, 
comprised of linearly placed giant polynuclear cells. 
Histopathologic examination performed after eight weeks of the study revealed the 
completed process of bone healing in group B. Bone structure was fully regenerated, and 
mature compact bone and cancellous bone could be observed at the defect site, along with 
normal bone marrow (Fig. 13). Observations made in the B+BG+TCP group after the 8th and 
12th weeks of the experiment gave similar findings. In this group bone defects were also 
filled with mature compact and cancellous skeletal tissue, with “incorporated” particles of 
bio-glass and deproteinized bone still visible (Fig. 14). These particles showed no signs of 
activity, and were covered with thin fibrous capsules. In the 8th experimental week, these 
particles could also be observed in fibrous connective tissue. After the 8th week of the study, 
the process of osteogenesis was still incomplete in B+BG and B+TCP specimens. In defects 
implanted with bio-glass, some areas, usually peripheral ones, were still filled with fibrous 
connective tissue containing numerous collagen fibers. This connective tissue showed signs 
of ongoing bone formation: maturating or mature bone trabeculae, along with bio-glass 
particles forming pseudocystic structures (Fig. 15). Particles of deproteinized bone were 
more rarely evidenced. At the same time, continued bone formation was observed in the 
central part of bone defects in group B+TCP (Fig. 16). This process was particularly 
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intensive around the B particles, giving the characteristic impression of “incorporating” this 
material into newly formed bone. After eight weeks of the study, only some bone trabeculae 
in the control group showed signs of osteoblastic activity, while other areas of the defect 
contained mature trabeculae. 
 
Fig. 9. Histopathologic specimen – 3rd week, group B – single osteoclasts on the surface of 
bone trabeculae (H&E staining, magnification 400 x) 
 
Fig. 10. Histopathologic specimen – 3rd week, group B+TCP – regeneration of skeletal tissue 
around fragments of deproteinized human bone and tricalcium phosphate (H&E staining, 
magnification 200 x) 
www.intechopen.com
 




Fig. 11. Histopathologic specimen – 3rd week, group B+BG+TCP – numerous bone 
trabeculae around the implanted material visible within fibrous connective tissue (H&E 
staining, magnification 40 x) 
 
Fig. 12. Histopathologic specimen – 4th week, group B+BG – mature bone trabeculae with no 
signs of cellular activity, along with particles of deproteinized human bone and bio-glass 
visible within fibrous connective tissue (H&E staining, magnification 40 x) 
After 12 weeks of the study, the process of skeletal tissue regeneration in specimens from 
groups B+BG and B+TCP was still not complete. Although the defects were nearly filled in 
their entirety with mature compact and cancellous bone, mature fibrous connective tissue 
containing numerous collagen fibers and showing signs of ongoing osteogenesis could still 
be seen in the superficial zone (Fig. 17). This superficial layer contained remnants of 
deproteinized bone, covered with capsules comprised of giant polynuclear cells, which 
formed inactive, fibrous foreign body granulomas. Additionally, cystic structures containing 
foggy remnants of incompletely resorbed TCP (group B+TCP) or BG particles (group B+BG) 
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were revealed in fibrous connective tissue (Fig. 18). In the control group, specimens 
obtained in the 12th week of the study contained completely matured and fully mineralized 
bone. 
 
Fig. 13. Histopathologic specimen – 8th week, group B – mature skeletal tissue and bone 
marrow (H&E staining, magnification 100 x) 
 
Fig. 14. Histopathologic specimen – 8th week, group B+BG+TCP – mature compact and 
cancellous skeletal tissue with “incorporated” particles of bio-glass and human bone (H&E 
staining, magnification 100 x) 
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Fig. 15. Histopathologic specimen – 8th week, group B+BG – bio-glass particle forming 
pseudocystic structure within the mature fibrous connective tissue (H&E staining, 
magnification 100 x) 
 
Fig. 16. Histopathologic specimen – 8th week, group B+TCP – fibrous connective tissue with 
massive osteogenesis (H&E staining, magnification 100 x) 
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Fig. 17. Histopathologic specimen – 12th week, group B+BG – mature fibrous connective tissue 
with numerous cystic spaces filled with foggy deposits of bio-glass (H&E staining, 100 x) 
 
Fig. 18. Histopathologic specimen – 12th week, group B+TCP – cystic structures within 
fibrous connective tissue containing foggy remnants of tricalcium phosphate (H&E staining, 
200 x) 
6. Discussion 
Due to the limited regenerative ability of skeletal tissue, bone grafting or the implantation of 
bone derivatives or bone replacement materials is required for the complete healing of large 
bone defects, whether the result of surgical removal of skeletal cysts or tumors, or caused by 
other skeletal disorders (Precheur, 2007). The most satisfactory results in stimulating skeletal 
tissue regeneration have been reported after using autogenous grafts. After being implanted 
into the bone defect, autogenous grafts can induce all the basic mechanisms responsible for 
bone reconstruction, i.e. osteogenesis, osteoinduction and osteoconduction (Giannoudis et 
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al., 2005; Merkx et al., 2003). Osteogenic activity is associated with the presence of 
osteoprogenitor cells in the periosteum, endosteum and bone marrow. In the case of free 
bone grafts, some of the cells located most superficially may survive and are involved in 
regeneration processes. The results of bone healing stimulation are definitely most 
satisfactory when autogenous cancellous bone chips are implanted, since this type of bone 
contains a high number of osteoprogenitor cells. Osteogenic activity can only be observed in 
fresh bone grafts. Osteoinduction is associated with the presence of so-called bone 
morphogenetic proteins (BMP) in the bone matrix. These proteins are released during bone 
remodeling, and can stimulate minimally differentiated connective tissue cells surrounding 
the graft to transform into osteoblasts (Barradas et al., 2011). Both fresh autogenic bone 
grafts and the allogenic grafts obtained from tissue bank (especially when frozen and partly 
decalcified) have osteoinductive properties. Additionally, BMP preparations can be 
obtained by extraction from bones, and as of recent, also by biotechnological synthesis in 
recombinant form. Allogenic bones are very frequently lyophilized, which depletes them of 
BMP. Additionally, such grafts lose their immunogenic properties due to irradiation 
sterilization and deep freezing (Bohner, 2010; Liu et al., 2008). This process of sterilization 
results in decreased durability of the material, and the preserved bone matrix has only 
osteoconductive properties. It is degraded by osteoclasts with the simultaneous formation of 
woven bone, which is further transformed into lamellar bone through the process of 
osteoclasia. Such grafts have been shown to undergo revascularization and remodeling – 
similar to autogenous grafts, but at a slower rate. Apart from bone implants, organic and 
inorganic alloplastic bone replacement materials also have osteoconductive properties. 
Combined with growth factors and autogenous barrier membranes, they are frequently 
used as basic elements in the process of guided bone regeneration (GBR) (Kao & Scott, 2007; 
Schwarz et al., 2007). 
For various reasons, different bone materials are frequently combined with each other or 
with alloplastic biomaterials. As a result, biologically improved material compositions are 
obtained, some of which positively influence the bone formation processes. Combination of 
natural hydroxyapatite with chitosane resulted in a composite with osteoconductive 
properties. In the presence of this composite, tibial consolidation in rabbits was observed as 
early as 12 weeks after implantation, and complete healing was observed after 16 weeks of 
the study (Yuan et al., 2008). In another study, a composite based on bovine bone with the 
addition of bio-glass showed no cytotoxicity to human fibroblasts. Moreover, a crystalline 
carbonated apatite phase was developed on the sample surface as early as 12 days after 
immersion in simulated body fluid (Yoganad e al., 2010). Another example of the positive 
effects of combining deproteinized bovine bone with autogenous bone comes from a study 
in which such a material was used for the regeneration of bone defects in the frontal part of 
the porcine skull. The presence of autogenous bone in the mixture was the basis for the 
osteoinductive properties of the material and the more favorable biological conditions for 
bone growth when compared to deproteinized bovine bone alone (Thorwarth et al., 2006). 
Similarly, more satisfactory clinical results were reported when deproteinized bovine bone 
was used in combination with autogenous bone in the management of alveoschisis in 
humans, instead of bone autograft alone (Thuaksuban et al., 2010). Experiments on rabbits 
have also given interesting results. It was revealed that the addition of deproteinized bovine 
bone to autogenous grafts increased the mean optical density of newly formed skeletal 
tissue, with a simultaneous decrease in its content in bone defects (skullcap). The opposite 
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effects were observed when autogenous bone graft was used alone (Pripatnanont et al., 
2009). Using a mixture of allogenic bone and deproteinized bovine bone 
(BioOss®/Orthoblast II®) for the purposes of maxillary sinus lift did not have results as  
satisfactory as with the application of deproteinized animal bone or synthetic bone 
(Osteon®) alone. The individual use of one of these two implant materials was associated 
with a higher percentage of newly formed osseous fraction collected from the lateral sinus at 
4 and 6 months post-operatively (Kim et al., 2009).  
In this study we have combined allogenic bone with artificially obtained biomaterials (bio-
glass – BG, and/or beta-tricalcium phosphate – TCP) in order to form bone replacement 
material with improved biological characteristics. Reference materials for comparative 
analysis of the studied mixtures (B+BG, B+TCP, B+BG+TCP) included lyophilized human 
bone (B) and the clotted blood of experimental animals. Both clinical observations and 
further macroscopic, radiographic and histopathologic examinations confirmed that bone 
defects healed normally in the presence of all studied biomaterials. However, the type of 
implanted mixture modulated the kinetics of bone formation and the quality of newly 
formed bone. Bone regeneration was induced markedly earlier whenever biologically active 
bio-glass was included in the implanted mixture (B+BG, B+BG+TCP). In groups where bio-
glass was implanted, irregular shadows were observed on radiographic images of the bone 
defect sites as early as after two weeks of the study. Probably, these radiographic changes 
resulted from ongoing reparative processes within the bone. This was additionally 
confirmed on histopathologic analysis, which revealed intense bone formation processes as 
early as three weeks after the implantation of BG-containing material. However, bone 
density measurements (BMD and CT bone density) taken in the early period of this study 
confirmed the superior quality of newly formed bone only in case of the B+BG mixture. It is 
plausible that the lower bone densities determined for B+BG+TCP implants resulted from 
the low content of bio-glass in this mixture. Moreover, as confirmed by histopathologic 
analysis, resorption of beta-tricalcium phosphate contained in B+BG+TCP already began in 
the early period of this study. Nonetheless, in the later period of this study, increases in 
BMD and CT bone density of B+BG implanted bone were markedly lower. As a result, after 
12 weeks of the experiment, the defects filled with this mixture were characterized by the 
lowest BMD values, and histopathologic examination confirmed ongoing bone formation. 
The final result of bone regeneration was markedly better in the case of defects implanted 
with B+BG+TCP. In the 12th week, histopathologic analysis revealed mature skeletal tissue 
(both compact and cancellous bone) at the implantation sites, and this finding was 
confirmed on radiographic examination. Additionally, new bone formed using B+BG+TCP 
implantation was characterized by the highest BMD and relatively high CT bone density. 
Therefore, this regenerated bone most closely resembled the normal skeletal tissue of 
experimental animals of all mixtures examined. In the 12th week of this study, bone 
formation processes were still observed in B+TCP implanted defects. Although the BMD of 
tissue formed on the basis of this implant was higher than in the B+BG implanted bone, it 
was still lower than in the B+BG+TCP group. Notably, in both the 1st and 12th experimental 
weeks, only slight differences in BMD and CT bone density were observed between the 
B+TCP and B+BG+TCP mixtures. Undoubtedly, the process of bone defect regeneration was 
completed the earliest in group B. Histopathologic studies confirmed that bone defects in 
this group were filled with mature skeletal tissue with no signs of osteoblastic activity as 
early as after eight weeks of the study. Early completion of skeletal healing was also 
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confirmed by the radiographic images taken in this group. In the 12th experimental week, 
BMD of bone defects implanted with human bone alone was higher in comparison to 
defects filled with B+TCP and B+BG+TCP, in contrast to the early period of this study when 
BMD and CT bone density in group B were among the highest.  
Results of this study suggest that the quality of bone formed in the late period of the 
experiment was poorest in the control group, as suggested by the low bone density of 
defects healing on the basis of clotted blood. Since histopathologic studies confirmed that 
bone formation in controls was complete in week 12, one should not expect further increases 
in bone density in this group. It is likely that bone density would increase further, however, 
with prolonged observation of the B+BG and B+TCP groups, since the last densitometric 
measurements in these groups were taken on incompletely matured bone. 
7. Conclusion 
This in vivo animal study revealed that both lyophilized human bone (B) and mixtures 
formed on its basis (B+BG, B+TCP, B+BG+TCP) are fully biocompatible materials. We have 
confirmed that, in the presence of these materials, there is a possibility of forming normal, 
mature skeletal tissue in mandibular bone defects of guinea pigs. This was possible mostly 
thanks to the inclusion of deproteinized human bone in analyzed mixtures. Due to its 
osteoconductive properties, the presence of human bone resulted in favorable biological 
conditions that promoted skeletal regeneration. Therefore, deproteinized bone formed a 
scaffold to support the growth of osteogenic cells within the defects. Furthermore, the 
addition of alloplastic materials, bio-glass and beta-tricalcium phosphate, markedly 
influenced the rate of bone formation and the quality of newly formed bone. The most 
satisfactory results were observed in the case of lyophilized human bone mixed with bio-
glass and beta-tricalcium phosphate (B+BG+TCP). The group implanted with this material 
was the only one in which fully matured compact and cancellous bone was observed on 
histopathologic examination performed after 12 weeks of the study. The particles of bio-
glass and beta-tricalcium phosphate included in the mixture induced the processes of bone 
formation and stimulated the growth of osteogenic cells. As a result of these initiated 
biological processes, defragmented and resorbed ǃ-TCP was gradually replaced with newly 
formed skeletal structures. Such a course of bone formation process modulated the quality 
of newly formed bone, as confirmed by high BMD and CT bone density values determined 
after 12 weeks in B+BG+TCP implanted defects. As confirmed on histopathologic 
examination, throughout the three-month period of this study, skeletal regeneration was not 
completed in defects implanted with B+BG and B+TCP mixtures. This incomplete 
regeneration was reflected by the lower bone density values observed in these groups when 
compared to the B+BG+TCP group. In conclusion, the results of this study confirmed our 
initial assumptions. We have revealed that, in addition to a proper course of bone formation 
processes, another important outcome in the presence of various bone replacement 
materials is the high quality of newly formed bone. In our opinion, these two 
aforementioned results were positively achieved by the mixture of lyophilized human bone 
with bio-glass and tricalcium phosphate.  
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